Neils Scott C 4
4 · Xtant Medical Holdings, Inc. · Filed Jan 18, 2022
Insider Transaction Report
Form 4
Neils Scott C
CFO and Assistant Secretary
Transactions
- Award
Stock Option (right to buy)
2022-01-15+109,164→ 109,164 totalExercise: $0.65Exp: 2032-01-15→ Common Stock (109,164 underlying) - Award
Common Stock, $0.000001 par value
2022-01-15+88,983→ 167,108 total
Footnotes (3)
- [F1]These shares will vest and be issued with respect to 22,246 shares on each of January 15, 2023, January 15, 2024, and January 15, 2025 and with respect to 22,245 shares on January 15, 2026 pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date.
- [F2]Includes 78,125 shares that will be issued over time subject to vesting pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan and 88,983 shares that will be issued over time subject to vesting pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan.
- [F3]This option vests with respect to 27,291 shares on January 15, 2023 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date.